Cargando…

Prediction of gastrointestinal toxicity after external beam radiotherapy for localized prostate cancer

BACKGROUND: Gastrointestinal (GI) toxicity is a common effect following radiation therapy (RT) for prostate cancer. Purpose of the present work is to compare two Normal Tissue Complication Probability (NTCP) modelling approaches for prediction of late radio-induced GI toxicity after prostate externa...

Descripción completa

Detalles Bibliográficos
Autores principales:	D’Avino, Vittoria, Palma, Giuseppe, Liuzzi, Raffaele, Conson, Manuel, Doria, Francesca, Salvatore, Marco, Pacelli, Roberto, Cella, Laura
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4404272/ https://www.ncbi.nlm.nih.gov/pubmed/25890376 http://dx.doi.org/10.1186/s13014-015-0389-5

Ejemplares similares

Multivariate normal tissue complication probability modeling of gastrointestinal toxicity after external beam radiotherapy for localized prostate cancer
por: Cella, Laura, et al.
Publicado: (2013)

Development of multivariate NTCP models for radiation-induced hypothyroidism: a comparative analysis
por: Cella, Laura, et al.
Publicado: (2012)

Auto- versus human-driven plan in mediastinal Hodgkin lymphoma radiation treatment
por: Clemente, Stefania, et al.
Publicado: (2018)

Complication Probability Models for Radiation-Induced Heart Valvular Dysfunction: Do Heart-Lung Interactions Play a Role?
por: Cella, Laura, et al.
Publicado: (2014)

Radiotherapy of large target volumes in Hodgkin's lymphoma: normal tissue sparing capability of forward IMRT versus conventional techniques
por: Cella, Laura, et al.
Publicado: (2010)

Ionizing Radiation Detectors Based on Ge-Doped Optical Fibers Inserted in Resonant Cavities
por: Avino, Saverio, et al.
Publicado: (2015)

Dose–Response of TLD-100 in the Dose Range Useful for Hypofractionated Radiotherapy
por: Liuzzi, Raffaele, et al.
Publicado: (2020)

Evaluation of LiF:Mg,Ti (TLD-100) for Intraoperative Electron Radiation Therapy Quality Assurance
por: Liuzzi, Raffaele, et al.
Publicado: (2015)

Radiation therapy following surgery for localized breast cancer: outcome prediction by classical prognostic factors and approximated genetic subtypes
por: Pacelli, Roberto, et al.
Publicado: (2013)

Voxel-based analysis unveils regional dose differences associated with radiation-induced morbidity in head and neck cancer patients
por: Monti, Serena, et al.
Publicado: (2017)

Radiation therapy in primary orbital lymphoma: a single institution retrospective analysis
por: De Cicco, Luigi, et al.
Publicado: (2009)

Long-Term (10-Year) Gastrointestinal and Genitourinary Toxicity after Treatment with External Beam Radiotherapy, Radical Prostatectomy, or Brachytherapy for Prostate Cancer
por: Hunter, Grant K., et al.
Publicado: (2012)

Hypofractionated External-Beam Radiotherapy for Prostate Cancer
por: Cho, L. Chinsoo, et al.
Publicado: (2013)

External beam radiotherapy for localized prostate cancer
por: Yilmaz, Hasan, et al.
Publicado: (2015)

Hodgkin’s lymphoma emerging radiation treatment techniques: trade-offs between late radio-induced toxicities and secondary malignant neoplasms
por: Cella, Laura, et al.
Publicado: (2013)

Comparison of chronic gastrointestinal and genitourinary toxicities between brachytherapy and external beam radiotherapy for patients with prostate cancer: A systematic review and meta-analysis
por: Li, Xuanzhe, et al.
Publicado: (2023)

Comparison of toxicities between ultrahypofractionated radiotherapy versus brachytherapy with or without external beam radiotherapy for clinically localized prostate cancer
por: Yamazaki, Hideya, et al.
Publicado: (2022)

Effects of Gold Fiducial Marker Implantation on Tumor Control and Toxicity in External Beam Radiotherapy of Prostate Cancer
por: Moll, Matthias, et al.
Publicado: (2023)

Potential benefits of using radioactive ion beams for range margin reduction in carbon ion therapy
por: Sokol, Olga, et al.
Publicado: (2022)

Prostate only radiotherapy using external beam radiotherapy: A clinician’s perspective
por: Lee, Jeong Won, et al.
Publicado: (2022)

Biochemical failure and toxicity in treatment with brachytherapy and external beam radiotherapy compared with radical prostatectomy in localized prostate cancer
por: Galdos-Bejar, Marcelo, et al.
Publicado: (2022)

Prostate-specific antigen kinetics following hypofractionated stereotactic body radiotherapy boost as post-external beam radiotherapy versus conventionally fractionated external beam radiotherapy for localized prostate cancer
por: Phak, Jeong Hoon, et al.
Publicado: (2016)

Survival Significance of Patients With Low Prostate-Specific Antigen and High-Grade Prostate Cancer After Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy
por: Guo, Yadong, et al.
Publicado: (2019)

Biological-effective versus conventional dose volume histograms correlated with late genitourinary and gastrointestinal toxicity after external beam radiotherapy for prostate cancer: a matched pair analysis
por: Jani, Ashesh B, et al.
Publicado: (2003)

Body mass index can affect gastrointestinal and genitourinary toxicity in patients with prostate cancer treated with external beam radiation therapy
por: DOI, HIROSHI, et al.
Publicado: (2014)

An external validation of the Candiolo nomogram in a cohort of prostate cancer patients treated by external‐beam radiotherapy
por: Gabriele, Domenico, et al.
Publicado: (2021)

High-dose-rate brachytherapy with external beam radiotherapy versus low-dose-rate brachytherapy with or without external beam radiotherapy for clinically localized prostate cancer
por: Yamazaki, Hideya, et al.
Publicado: (2021)

Salvage brachytherapy for locally recurrent prostate cancer after external beam radiotherapy
por: Yamada, Yasuhiro, et al.
Publicado: (2015)

The Use of Ultrasound Imaging in the External Beam Radiotherapy Workflow of Prostate Cancer Patients
por: Camps, Saskia M., et al.
Publicado: (2018)

Comparison of radical prostatectomy and external beam radiotherapy in high-risk prostate cancer
por: Chun, Seok-Joo, et al.
Publicado: (2021)

Maintaining consistent bladder filling during external beam radiotherapy for prostate cancer
por: Nasser, Nicola J., et al.
Publicado: (2021)

External beam radiotherapy for prostate cancer: What are the current research trends and hotspots?
por: Li, Rui, et al.
Publicado: (2021)

Seminal Vesicle Treatment for Localized Prostate Cancer Treated with External Beam Radiotherapy
por: Steed, Tanner, et al.
Publicado: (2023)

Reduction of margins in external beam radiotherapy
por: Kron, Tomas
Publicado: (2008)

Self-assessed bowel toxicity after external beam radiotherapy for prostate cancer - predictive factors on irritative symptoms, incontinence and rectal bleeding
por: Pinkawa, Michael, et al.
Publicado: (2009)

Inter-patient image registration algorithms to disentangle regional dose bioeffects
por: Monti, Serena, et al.
Publicado: (2018)

Effect of patient thickness on acute gastrointestinal toxicities following radiotherapy for prostate cancer
por: Pisani, Robert, et al.
Publicado: (2021)

Hypofractionated Proton Boost Combined with External Beam Radiotherapy for Treatment of Localized Prostate Cancer
por: Johansson, Silvia, et al.
Publicado: (2012)

The role of salvage brachytherapy for local relapse after external beam radiotherapy for prostate cancer
por: Tisseverasinghe, Steven A., et al.
Publicado: (2018)

The effectiveness and side effects of conformal external beam radiotherapy combined with high-dose-rate brachytherapy boost compared to conformal external beam radiotherapy alone in patients with prostate cancer
por: Smolska-Ciszewska, Beata, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_soesh6mnv4va7tbl4k3gl5eebp